Akso Health (AHG) Cost of Revenue (2017 - 2019)

Akso Health (AHG) has reported Cost of Revenue for 3 consecutive years, with $2.2 million the latest figure, recorded in Q3 2019.

• Quarterly Cost of Revenue rose 2.04% year-over-year to $2.2 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $8.3 million (down 6.22% YoY) and the FY2026 annual result came in at $13.8 million, down 8.08% from the prior year.
• Cost of Revenue advanced to $2.2 million in Q3 2019 per AHG's latest filing, from $1.6 million in the prior quarter.
• Over the last five years, Cost of Revenue for AHG reached as high as $3.2 million in Q4 2017 and fell as low as $1.3 million in Q2 2017.
• A 3-year average of $2.0 million and a median of $2.1 million in 2018 frame the typical range for Cost of Revenue.
• The largest YoY upside for Cost of Revenue was 14.52% in 2018 against a maximum downside of 29.91% in 2018.
• Year by year, Cost of Revenue stood at $3.2 million in 2017, then dropped by 29.91% to $2.2 million in 2018, then declined by 1.1% to $2.2 million in 2019.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.2 million, $1.6 million, and $2.2 million for Q3 2019, Q1 2019, and Q4 2018 respectively.